CoChat

Therapeutic trial design for frontotemporal dementia and related disorders

Open access
Desmarais, Philippe, Rohrer, Jonathan D, Nguyen, Quoc Dinh, Herrmann, Nathan, Stuss, Donald T, Lang, Anthony E, Boxer, Adam L, Dickerson, Bradford C, Rosen, Howie, van Swieten, John Cornelis, Meeter, Lieke H, Borroni, Barbara, Tartaglia, Maria Carmela, Feldman, Howard H, Black, Sandra E, Masellis, Mario · 2019 · Journal of Neurology, Neurosurgery & Psychiatry
Cited by 33

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

The frontotemporal dementia (FTD) spectrum is a heterogeneous group of neurodegenerative syndromes with overlapping clinical, molecular and pathological features, all of which challenge the design of clinical trials in these conditions. To date, no pharmacological interventions have been proven effective in significantly modifying the course of these disorders. This study critically reviews the construct and methodology of previously published randomised controlled trials (RCTs) in FTD spectrum disorders in order to identify limitations and potential reasons for negative results. Moreover, recommendations based on the identified gaps are elaborated in order to guide future clinical trial design. A systematic literature review was carried out and presented in conformity with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria. A total of 23 RCTs in cohorts with diagnoses of behavioural and language variants of FTD, corticobasal syndrome and progressive supranuclear palsy syndrome were identified out of the 943 citations retrieved and were included in the qualitative review. Most studies identified were early-phase clinical trials that were small in size, short in duration and frequently underpowered. Diagnoses of populations enrolled in clinical trials were based on clinical presentation and rarely included precision-medicine tools, such as genetic and molecular testing. Uniformity and standardisation of research outcomes in the FTD spectrum are essential. Several elements should be carefully considered and planned in future clinical trials. We anticipate that precision-medicine approaches will be crucial to adequately address heterogeneity in the FTD spectrum research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp-2018-318603

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 33

Metadata

Authors
Desmarais, P., Rohrer, J. D., Nguyen, Q. D., Herrmann, N., Stuss, D. T., Lang, A. E., Boxer, A. L., Dickerson, B. C., Rosen, H., van Swieten, J. C., Meeter, L. H., Borroni, B., Tartaglia, M. C., Feldman, H. H., Black, S. E., & Masellis, M.
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2018-10-25
Volume
90
Issue
4
Pages
412-423
ISSN
  • 0022-3050 (ISSN-L)
  • 1468-330X
OpenAlex
W2898356427
Cited by
33
References
16
FWCI
2.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic trial design for frontotemporal dementia and related disorders. https://app.cochat.ai/papers/10.1136/jnnp-2018-318603
The paper
Desmarais, P., Rohrer, J. D., Nguyen, Q. D., Herrmann, N., Stuss, D. T., Lang, A. E., Boxer, A. L., Dickerson, B. C., Rosen, H., van Swieten, J. C., Meeter, L. H., Borroni, B., Tartaglia, M. C., Feldman, H. H., Black, S. E., & Masellis, M. (2019). Therapeutic trial design for frontotemporal dementia and related disorders. Journal of Neurology, Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2018-318603

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.